BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

418 related articles for article (PubMed ID: 27102817)

  • 1. Recombinant Newcastle disease virus expressing H9 HA protects chickens against heterologous avian influenza H9N2 virus challenge.
    Nagy A; Lee J; Mena I; Henningson J; Li Y; Ma J; Duff M; Li Y; Lang Y; Yang J; Abdallah F; Richt J; Ali A; García-Sastre A; Ma W
    Vaccine; 2016 May; 34(23):2537-45. PubMed ID: 27102817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel recombinant attenuated Newcastle disease virus expressing H9 subtype hemagglutinin protected chickens from challenge by genotype VII virulent Newcastle disease virus and H9N2 avian influenza virus.
    Xu X; Xue C; Liu X; Li J; Fei Y; Liu Z; Mu J; Bi Y; Qian J; Yin R; Ding Z
    Vet Microbiol; 2019 Jan; 228():173-180. PubMed ID: 30593364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chimeric Newcastle disease virus-vectored vaccine protects chickens against H9N2 avian influenza virus in the presence of pre-existing NDV immunity.
    Liu J; Xue L; Hu S; Cheng H; Deng Y; Hu Z; Wang X; Liu X
    Arch Virol; 2018 Dec; 163(12):3365-3371. PubMed ID: 30187143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccine Efficacy of Inactivated, Chimeric Hemagglutinin H9/H5N2 Avian Influenza Virus and Its Suitability for the Marker Vaccine Strategy.
    Kim SM; Kim YI; Park SJ; Kim EH; Kwon HI; Si YJ; Lee IW; Song MS; Choi YK
    J Virol; 2017 Mar; 91(6):. PubMed ID: 28077631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Newcastle disease virus (NDV) recombinant expressing the hemagglutinin of H7N9 avian influenza virus protects chickens against NDV and highly pathogenic avian influenza A (H7N9) virus challenges.
    Hu Z; Liu X; Jiao X; Liu X
    Vaccine; 2017 Dec; 35(48 Pt B):6585-6590. PubMed ID: 29042201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Newcastle disease virus-based live attenuated vaccine completely protects chickens and mice from lethal challenge of homologous and heterologous H5N1 avian influenza viruses.
    Ge J; Deng G; Wen Z; Tian G; Wang Y; Shi J; Wang X; Li Y; Hu S; Jiang Y; Yang C; Yu K; Bu Z; Chen H
    J Virol; 2007 Jan; 81(1):150-8. PubMed ID: 17050610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation and Evaluation of Recombinant Thermostable Newcastle Disease Virus Expressing the HA of H9N2 Avian Influenza Virus.
    Zhang X; Bo Z; Meng C; Chen Y; Zhang C; Cao Y; Wu Y
    Viruses; 2021 Aug; 13(8):. PubMed ID: 34452473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation and evaluation of a Newcastle disease virus-based H9 avian influenza live vaccine.
    Ge J; Tian G; Zeng X; Jiang Y; Chen H; Bua Z
    Avian Dis; 2010 Mar; 54(1 Suppl):294-6. PubMed ID: 20521648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunogenicity and protective efficacy of a multivalent herpesvirus vectored vaccine against H9N2 low pathogenic avian influenza in chicken.
    Ingrao F; Ngabirano E; Rauw F; Dauphin G; Lambrecht B
    Vaccine; 2024 May; 42(15):3410-3419. PubMed ID: 38641498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of an inactivated bivalent vaccine against the prevalent strains of Newcastle disease and H9N2 avian influenza.
    Zhao J; Yang H; Xu H; Ma Z; Zhang G
    Virol J; 2017 Mar; 14(1):56. PubMed ID: 28302119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Newcastle disease virus vectors expressing consensus sequence of the H7 HA protein protect broiler chickens and turkeys against highly pathogenic H7N8 virus.
    Roy Chowdhury I; Yeddula SGR; Pierce BG; Samal SK; Kim SH
    Vaccine; 2019 Aug; 37(35):4956-4962. PubMed ID: 31320218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chimeric Newcastle Disease Virus-like Particles Containing DC-Binding Peptide-Fused Haemagglutinin Protect Chickens from Virulent Newcastle Disease Virus and H9N2 Avian Influenza Virus Challenge.
    Xu X; Qian J; Qin L; Li J; Xue C; Ding J; Wang W; Ding W; Yin R; Jin N; Ding Z
    Virol Sin; 2020 Aug; 35(4):455-467. PubMed ID: 32274680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced cross-lineage protection induced by recombinant H9N2 avian influenza virus inactivated vaccine.
    Wang Z; Li Z; Su X; Qiao Y; Fan W; Li H; Shi B; Qin T; Chen S; Peng D; Liu X
    Vaccine; 2019 Mar; 37(13):1736-1742. PubMed ID: 30797637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective dose of a recombinant Newcastle disease LaSota-avian influenza virus H5 vaccine against H5N2 highly pathogenic avian influenza virus and velogenic viscerotropic Newcastle disease virus in broilers with high maternal antibody levels.
    Sarfati-Mizrahi D; Lozano-Dubernard B; Soto-Priante E; Castro-Peralta F; Flores-Castro R; Loza-Rubio E; Gay-Gutiérrez M
    Avian Dis; 2010 Mar; 54(1 Suppl):239-41. PubMed ID: 20521638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Level of protection of chickens against highly pathogenic H5 avian influenza virus with Newcastle disease virus based live attenuated vector vaccine depends on homology of H5 sequence between vaccine and challenge virus.
    Römer-Oberdörfer A; Veits J; Helferich D; Mettenleiter TC
    Vaccine; 2008 May; 26(19):2307-13. PubMed ID: 18395947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maternal antibody inhibition of recombinant Newcastle disease virus vectored vaccine in a primary or booster avian influenza vaccination program of broiler chickens.
    Bertran K; Lee DH; Criado MF; Balzli CL; Killmaster LF; Kapczynski DR; Swayne DE
    Vaccine; 2018 Oct; 36(43):6361-6372. PubMed ID: 30241684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of recombinant Newcastle disease virus expressing HA protein of H9N2 Avian influenza virus in respiratory and intestinal tract.
    Shao G; Xie Z; Liang M; Liu Y; Song C; Feng K; Zhang X; Lin W; Fu J; Xie Q
    Poult Sci; 2022 Dec; 101(12):102078. PubMed ID: 36272233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterologous prime-boost immunization of Newcastle disease virus vectored vaccines protected broiler chickens against highly pathogenic avian influenza and Newcastle disease viruses.
    Kim SH; Samal SK
    Vaccine; 2017 Jul; 35(33):4133-4139. PubMed ID: 28668574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccination with recombinant 4 × M2e.HSP70c fusion protein as a universal vaccine candidate enhances both humoral and cell-mediated immune responses and decreases viral shedding against experimental challenge of H9N2 influenza in chickens.
    Dabaghian M; Latify AM; Tebianian M; Nili H; Ranjbar AR; Mirjalili A; Mohammadi M; Banihashemi R; Ebrahimi SM
    Vet Microbiol; 2014 Nov; 174(1-2):116-26. PubMed ID: 25293397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Live recombinant Newcastle disease virus vectored vaccine expressing the haemagglutinin of H9N2 avian influenza virus suppresses viral replication in chickens.
    Lee J; Cho AY; Kim DH; Lee JB; Park SY; Choi IS; Lee SW; Song CS
    Avian Pathol; 2023 Apr; 52(2):100-107. PubMed ID: 36377478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.